Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Indazole Derivatives as Bcl-2/Mcl-1 Dual Inhibitors

被引:3
作者
Luo, Xi [1 ]
Deng, Xu [1 ]
Ruan, Jingyi [1 ]
Wang, Wenyan [1 ]
Wan, Yichao [1 ,2 ]
机构
[1] Hunan Univ Sci & Technol, Sch Chem & Chem Engn, Key Lab Theoret Organ Chem & Funct Mol, Minist Educ, Xiangtan 411201, Hunan, Peoples R China
[2] Hunan Univ Sci & Technol, Hunan Prov Key Lab Controllable Preparat & Funct, Hunan Prov Key Lab Adv Mat New Energy Storage & C, Xiangtan 411201, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Bcl-2; Mcl-1 dual inhibitors; indazole derivatives; anti-tumor; scaffold hopping;
D O I
10.1134/S1070363222060238
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this study, a series of new indazole derivatives has been designed, synthesized and evaluated for inhibitory activity against anti-apoptotic Bcl-2 proteins (Bcl-2, Mcl-1, Bcl-xL). Among them, three products have demonstrated high inhibitory activity against Bcl-2/Mcl-1, which is similar to that of the positive control compound WL-276. Their poor Bcl-xL inhibitory activity allows to avoid platelet toxicity caused by Bcl-xL inhibition. Hence, they might be considered as lead compounds for developing Bcl-2/Mcl-1 dual inhibitors of higher potency.
引用
收藏
页码:1109 / 1114
页数:6
相关论文
共 9 条
[1]   Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors [J].
Liu, Renshuai ;
Liu, Lulu ;
Liu, Tingting ;
Yang, Xinying ;
Wan, Yichao ;
Fang, Hao .
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (17) :4907-4915
[2]   Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry [J].
Mendgen, Thomas ;
Steuer, Christian ;
Klein, Christian D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) :743-753
[3]   Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia [J].
Roberts, Andrew W. ;
Davids, Matthew S. ;
Pagel, John M. ;
Kahl, Brad S. ;
Puvvada, Soham D. ;
Gerecitano, John F. ;
Kipps, Thomas J. ;
Anderson, Mary Ann ;
Brown, Jennifer R. ;
Gressick, Lori ;
Wong, Shekman ;
Dunbar, Martin ;
Zhu, Ming ;
Desai, Monali B. ;
Cerri, Elisa ;
Enschede, Sari Heitner ;
Humerickhouse, Rod A. ;
Wierda, William G. ;
Seymour, John F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (04) :311-322
[4]   Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors [J].
Wan, Yichao ;
Li, Yuanhua ;
Yan, Chunxing ;
Wen, Jiajun ;
Tang, Zilong .
BIOORGANIC CHEMISTRY, 2020, 104
[5]   Indazole Derivatives: Promising Anti-tumor Agents [J].
Wan, Yichao ;
He, Shengzhuo ;
Li, Wei ;
Tang, Zilong .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (09) :1228-1234
[6]   Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents [J].
Wan, Yichao ;
Dai, Ningning ;
Tang, Zilong ;
Fang, Hao .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 146 :471-482
[7]   Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors [J].
Wan, Yichao ;
Wang, Junhua ;
Sun, Feng'e ;
Chen, Minglu ;
Hou, Xuben ;
Fang, Hao .
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (24) :7685-7693
[8]   Design, synthesis and preliminary bioactivity studies of 2-thioxo-4-thiazolidinone derivatives as Bcl-2 inhibitors [J].
Wan, Yichao ;
Wu, Shaolei ;
Xiao, Guizhi ;
Liu, Tingting ;
Hou, Xuben ;
Chen, Chen ;
Guan, Peng ;
Yang, Xinying ;
Fang, Hao .
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (09) :1994-2003
[9]   WL-276, an antagonist against Bcl-2 proteins, overcomes drug resistance and suppresses prostate tumor growth [J].
Wang, Liangyou ;
Sloper, Daniel T. ;
Addo, Sadiya N. ;
Tian, Defeng ;
Slaton, Joel W. ;
Xing, Chengguo .
CANCER RESEARCH, 2008, 68 (11) :4377-4383